Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel

Despite clopidogrel has been widely applied to patients with ischemic stroke combined with aspirin, decreased metabolic activation of clopidogrel still occurs because of genetic variations in CYP2C19.

Source: Journal of the Neurological Sciences - August 13, 2016 Category: Neurology Authors: Yingting Wang, Huan Cai, Guoqing Zhou, Zhizhong Zhang, Xinfeng Liu Source Type: research